Table 2.
Antigen | Method | PL9-11 isotype | |||
---|---|---|---|---|---|
IgG3 | IgG1 | IgG2b | IgG2a | ||
500 bp dsDNA* | Gel analysis | + | − | ++ | + |
ALW 12AA peptideΔ | MALDI-TOF | + | +++ | ++ | + |
The catalytic strength was compared based on data shown in Figures 2b and 2c.
Antigen | Method | PL9-11 isotype | |||
---|---|---|---|---|---|
IgG3 | IgG1 | IgG2b | IgG2a | ||
500 bp dsDNA* | Gel analysis | + | − | ++ | + |
ALW 12AA peptideΔ | MALDI-TOF | + | +++ | ++ | + |
The catalytic strength was compared based on data shown in Figures 2b and 2c.